Dynamics of morphological indicators of blood in palliathic immunotherapy of mammary gland cancer in cats in incurrent cases
In the article results of researches on definition of influence of various recombinant interferons at palliative immunotherapy of a cancer of a mammary gland of cats in incurable cases on a morphology of a blood are stated. The object of the study was 69 cats of different breeds and age groups, with a morphologically confirmed diagnosis - breast cancer. The animals of the first group used the immunomodulator "Layfferon", the second - "Recoeferon-Gamma", the third - "Feliferon". The drugs were injected intramuscularly, into the thigh, at a dose of 50,000 IU / kg animal weight, every 24 hours, 10 injections. Then, according to the method developed and proposed by us, every 48 hours at the same dose, 10 injections. After immunotherapy with Leifferon, Recoferon-Gamma and Feliferon, the average leukocyte count increased by 15%, 27% and 24%, respectively. When carrying out palliative therapy in cats immunomodulators "Layfferon", "Recoferon-Gamma" and "Feliferon", no side effects and reactions of the organism affecting the overall somatic state of animals are noted. The best therapeutic effect is observed when using the species-specific interferon "Feliferon".